Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Kind Pharmaceutical
company
About
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $50M
- Industries
- Biopharma,Biotechnology,Health Care,Therapeutics
- Founded date
- Jul 1, 2014
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs. The company was founded in 2013 and is headquartered in Redwood City, California, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$50M
Kind Pharmaceutical has raised a total of
$50M
in funding over 2 rounds. Their latest funding was raised on
Dec 27, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 27, 2021 | Series B | $50M | 2 |
Gaorong Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Kind Pharmaceutical is funded by 2 investors.
Gaorong Capital
and Ancheng Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Gaorong Capital
|
Yes | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
